Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.
Gui-shuang Ying; Maureen G Maguire; Judith Alexander; Revell W Martin; Andrew N Antoszyk; (Profiled Author: Maureen Maguire)
Scheie EyeInstitute, University ofPennsylvania, Philadelphia, PA 19104-3309, USA. gsying@mail.med.upenn.edu
Archives of ophthalmology 2009;127(9):1147-51.
OBJECTIVE: To describe characteristics of the Age-Related Eye Disease Study (AREDS) 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). METHODS: Eligibility criteria for CAPT required 10 or more large (>or=125 microm) drusen in each eye. Readers graded baseline photographs from all participants and all follow-up photographs from 402 untreated eyes. Drusen and pigment characteristics were used to assign the AREDS scale score. Choroidal neovascularization was identified from fluorescein angiograms. Geographic atrophy involving the macular center was identified from color photographs. RESULTS: Among 1001 untreated eyes, 90% were at steps 5 to 7 at baseline. The 5-year incidence of advanced age-related macular degeneration (AMD) increased with each step from 8% (step 4) to 40% (steps 8 and 9 combined). These rates were similar to those reported in AREDS. Among 261 eyes with all 5 annual photograph gradings available and without progression to advanced AMD, 55% of eyes had scores that indicated improvement at least once. Before progression to advanced AMD, only 32% of 141 eyes either went through step 8 or 9 or had an increase of 2 or more steps from baseline. CONCLUSIONS: The AREDS 9-step severity scale was predictive of development of advanced AMD. The AREDS scale has deficiencies as a surrogate outcome for progression to advanced AMD.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2005Matthew D Davis; Ronald E Gangnon; Li-Yin Lee; Larry D Hubbard; Barbara E K Klein; Ronald Klein; Frederick L Ferris; Susan B Bressler; Roy C Milton;
Archives of ophthalmology 2005;123(11):1484-98. -
2.
2003Jonathan L Prenner; Brett J Rosenblatt; Michael J Tolentino; Gui-Shang Ying; Norren B Javornik; Maureen G Maguire; Allen C Ho;
Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT.
Retina (Philadelphia, Pa.) 2003;23(3):307-14. -
3.
2001R S Kaiser; J W Berger; M G Maguire; A C Ho; N B Javornik;
Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study.
Archives of ophthalmology 2001;119(6):826-32.

Appears in this Publication







